Abstract
Background:
Toxoplasma gondii coinfection can modify host immune responses and the severity and spread of other parasites. We investigated how T. gondii and Trichinella spiralis infections counter-regulate each other's immune responses.
Methods:
The parasite burden, the expression of T. gondii rhoptry kinase ROP18 and T. spiralis putative serine protease (TsSP), the IgG1 and IgG2a responses, besides histopathological and immunohistochemical staining with iNOS and arginase were used to evaluate the dynamics of coinfection.
Results:
Through their effects on host immune responsiveness, coinfection with T. gondii modified the virulence of T. spiralis infection. Coinfected animals with high and low doses of T. gondii demonstrated significant reductions in the T. spiralis burden of 75.2% and 68.2%, respectively. TsSP expression was downregulated in both groups by 96.2% and 86.7%, whereasROP18 expression was downregulated by only 6% and10.6%, respectively. In coinfected mice, elevated levels of T. gondii-specific IgG2a antibodies were detected. Th1 induced by T. gondii inhibits the Th2 response to T. spiralis in coinfected animals with high iNOS expression andlow-arginine1 expression.
Conclusion:
T. gondii infection induces a shift toward a Th1-type immune response while suppressing a helminth-specific Th2 immune response, paving the way for developing novel vaccines and more efficient control strategies.
Keywords: Coinfection, Toxoplasma gondii, Trichinella spiralis, Arginase1
Introduction
Coinfection with many parasite or pathogen species is likely to be the norm rather than the exception in most biological systems, including human societies with limited medical access. The interactions of many common parasites and pathogens are poorly understood, despite the fact that co-infection research is common for diseases. Coinfection must be investigated because it can alter both treatment and susceptibility to infection (1). Furthermore, coexposure to multiple pathogens is a natural occurrence (2), and coinfection affects more than one-sixth of the world's population (3). The interaction between two or more co-infecting parasites can have various repercussions. It may contribute to the aggravation or amelioration of the pathophysiology of either infection by modifying the immune profile and/or parasite interactions (4).
Currently, more than 2 billion people are infected with helminth parasites, which cause serious, neglected tropical diseases in both humans and animals (5). Helminths can infect and remain in their hosts for extended periods of time, causing chronic infections with severe health consequences for the host. They suppress the immune response to maintain their life cycle (6).
Trichinella spiralis is the primary agent responsible for trichinosis, which affects 12 million individuals worldwide (7). The immune evasion of T. spiralis and stage-specific antigen diversity present obstacles to the development of effective vaccines. In most nematode-endemic regions, toxoplasmosis, malaria, and tuberculosis typically co-occur (8).
The parasite Toxoplasma gondii infects warm-blooded vertebrates via the gastrointestinal tract, causing a dormant stage in muscle and brain tissue (9). In some regions, T. gondii seroprevalence can approach 70%, with most immunocompetent individuals being asymptomatic and at a high risk of coinfection with other parasites found in the general population (10). In contrast to helminth infections, T. gondii infection is controlled by an entirely different immune response.
IgG1 and IgE antibodies are characteristic of helminth infections, which are characterized by the activation of CD4+ T helper 2 (Th2) cells that produce the cytokines interleukin IL-13, IL-9, IL-5, and IL-4 (11). In contrast, protozoal infections induce a Th1 response that produces pro-inflammatory mediators such as IFN, nitric oxide, and IL-12. These two types of immune responses counter-regulate each other; therefore, enhancing one type of immune response inhibits the other (12). T. gondii possesses a pathogenicity locus referred to as T. gondii rhoptry kinase (ROP18), a highly polymorphic rhoptry protein kinase that is significantly expressed in type I and II strains (13). Serine protease is a proteolytic enzyme that contributes to parasite tissue penetration, larval development, and survival, while TsSP is a sensitive and specific early diagnostic marker for trichinellosis detection (14).
In this study, the parasite burden, ROP18, TsSP expression, and antibody response (IgG1 & IgG2a) in mice infected with a single or mixed dose of both parasites were analyzed to gain a better understanding of the dynamics of coinfection with T. gondii and T. spiralis besides to how the distinct immune responses induced by each parasite counter-regulate the other. Histopathological evaluations, iNOS, and arginase immunohistochemical staining were performed.
Materials and Methods
Animals
Male Swiss albino mice were raised in the animal house under specified pathogen-free conditions using 8-week-old Swiss albino mice purchased from the Animal House at Faculty of Medicine, Zagazig University, Egypt.
The tests were approved by the Animal Ethics Committee for Animal Protection and conducted in accordance with the National Animal Protection Guidelines (ZU-IACUC/3/F/165/2022).
T. gondii Infection
The T. gondii ME49 strain was obtained from the Department of Parasitology, Faculty of Medicine, Zagazig University, and then maintained through continuous passage in cyst-infected mice. The parasite cysts were obtained from infected mice with chronic infections. Following animal sacrifice, the brain of a mouse was homogenized in saline. The cyst count in the homogenate was determined using light microscopy (15). The infection was administered orally to mice at either a low dose of 10-tissue cysts/animal (16) or a high dose of 100-tissue cysts/mouse (17).
T. spiralis infection
The employed T. spiralis isolate was initially isolated from diseased pork in Cairo and maintained in the laboratory of the Medical Parasitology Department at Faculty of Medicine, Zagazig through repeated passages in mice. Muscle larvae were obtained from experimentally infected mice with T. spiralis 42 days post infection (dpi) (18). A high dose of 400 larvae per mouse was administered orally (19).
Experiment
Six groups of ten mice each, were categorized as controls: group I; naive mice, group II; mice inoculated with an elevated dose of T. gondii, group III; mice infected with a low dose of T. gondii, group IV; and mice infected with T. spiralis. Furthermore, group V consisted of mice that were coinfected with high doses of T. gondii and T. spiralis, whereas group VI consisted of mice that were coinfected with low doses of T. gondii and T. spiralis. All mice groups were infected at the same time.
Parasitological assessment
Survival rate
Throughout the duration of the experiment, the daily death rate of mice was recorded, and the survival rate was determined.
Collection of T. spiralis larvae in muscles
On day 42-post infection, the muscular phase of infection and the burden of muscle larvae were examined using artificial digestion (20, 21). The sediment was tallied using a stereomicroscope at 40× magnification.
Toxoplasma gondii brain cyst burden
At the chronic phase (42 days post infection) phase, brains with tissue cysts were obtained from each group, homogenized, stained with Giemsa stain, and counted under a microscope (22).
T. gondii ROP18 and T. spiralis serine pro-tease
The QIAamp RNeasy Mini kit (Qiagen, Germany, GmbH) was used to extract RNA from tissue Animal Tissues protocol of the manufacture kits was followed.
Oligonucleotide primers
The used primers were supplied by Metabion (Germany). Primer sequences for gene amplification were T. gondii ß actin forward: TCCCGTCTATCGTCGGA-AAG, reverse CCATTCCGACCATGATAC (23), T. gondii ROP18 forward: CGCTGGTGAGAGGTGCAC, reverse: GACCGTCTTTCAAGAGGAGG (24), T.spiralis GAPDH forward: GCAGCTATGGATGTTCAGGTG, reverse: TACGGCTGACAGCATGATTT (25), T. spiralis serine protease: forward: CTT TTCAAGTGCTTATTTCTC, reverse TATTACCCGCTTTTCTGAA (14).
Analysis of the SYBR green rt-PCR results.
Standard curves and Ct of the targeted genes were determined by Agilent MX3005P software. The obtained threshold of each sample was compared with that of the positive control to estimate the variation of gene expression consistent with Yuan et al. (26).
Determination of antigen- specific IgG subtypes
The ELISA RayBio® method identified specific IgG1 and IgG2a antibodies against T. gondii and T. spiralis. The optical density at 450 nm was measured using a Biotech ELx800 microplate reader (Biotech, USA).
Histopathological assessment
Samples of formalin-preserved muscle and brain samples were fixed and dehydrated. The 4–5 um paraffin sections were stained with Hematoxylin and eosin (27).
Immunohistochemistry (Arginase and iNOS expression)
Standard immunohistochemical procedures were used, and the tissue slices were microwaved to distinguish the antigen’s epitopes (28). Immunostaining requires a two-step process. Firstly, the binding of the primary antibody to the related antigen, followed by visualization of reaction by a link antibody to which are attached different enzyme systems. In addition, the biotin-streptavidin (BSA) system to view the markers (28). Diaminobenzidine (DAB) was used as a chromogen because it permits a permanent preparation, while Hematoxylin was used as a contrast dye. The sections were then treated with one to two drops of the ultrasensitive monoclonal primary antibody [against inducible nitric oxide synthase (INOS) and arginase (ARG)].
Statistics
The results were displayed as the mean ±SEM. Statistical analysis was performed using GraphPad Prism. In order to determine the level of significance, the Mann–Whitney U-test or Kruskal–Wallis and Dunn’s multiple comparison tests were used.
Results
The T. spiralis larval load was significantly reduced in GV (coinfected with T. spiralis and a high dose of T. gondii) and GVI (coinfected with T. spiralis and a low dose of T. gondii) compared with the T. spiralis-infected GIV control. The T. gondii brain cyst burden of the coinfected GV compared to the control GII infected with high doses of T. gondii and the coinfected GVI compared to the control GIII infected with low doses of T. gondii did not differ significantly between the two groups (Fig.1A, B).GV had the greatest reduction (75.2%) of T. spiralis larvae, followed by GVI with 68.2%, whereas GVI and GV had only modest reductions of T. gondii brain cyst burdens at10.2% and 8% (Fig.1H).
Fig. 1:
A dominant Th1 response elicited by T. gondii inhibits T. spiralis Th2 response, reducing T. spiralis larval burden, downregulating serine protease gene expression, and decreasing IgG2a antibody response in coinfected groups
T. spiralis putative serine protease (TsSP) expression was downregulated by 96.2% in GV and 86.7% in GVI compared with GIV, a statistically significant difference. The expression of T. gondii rhoptry kinase (ROP18) between the coinfected GV and the control GII, as well as between the coinfected GVI and the control GIII, did not differ statistically (Fig.1 C,D), while there was a negligible downregulation of ROP18 gene expression in GV and GVI (Fig.1H).
There was a highly statistically significant difference in the IgG2a antibody levels of the targeted coinfected GV, a statistically significant difference in the coinfected GVI, and no statistically significant difference in the IgG2a antibody levels of the GIV in comparison with the normal GI. Additionally, the serum levels of IgG1antibodies in the targeted coinfected GV and GVI did not differ significantly from those of the GI. GIV exhibited a high statistically significant difference (Fig.1 E, F).
Infection with T. spiralis larvae is associated with a mild inflammatory response of muscle tissue with preserved longitudinal cross striations and peripheral multinuclear arrangement (light blue arrows) in GV (Fig.2B).
Fig. 2:
Photomicrograph of H&E from muscle and brain, with scale bars of 25 and 50 um
In contrast to the control group GIV, which exhibited a severe T. spiralis infestation and a strong hypersensitive inflammatory reaction, GVI exhibited a moderate inflammatory reaction of mixed cellular type (Fig. 2C). In the vicinity of the parasite (dark blue arrows), muscle fibers exhibit pressure atrophy (light blue arrow), hyaline degeneration, marked congestion, edema, allergic myositis, and necrosis (black and yellow arrows) (Fig.2 A).In brain tissue, the embedded T. gondii bradyzoites appeared as dark bluish structures in the aggregated mass, whereas the control groups GII and GIII displayed vague cyst-like structures (black arrows) (Fig.2D). Additionally, the cerebral hemisphere demonstrated severe tissue reactions, including neuronal degeneration, neutrophils demyelination (dark blue arrow), microgliosis (yellow arrow), and focal periventricular oligodendrogliosis (light blue arrows), in addition to meningeal hyperemia with round cell infiltration (lymphocytic meningitis) (black arrows) in GV and GVI (Fig. 1E).
The production of iNOS was examined in brain and muscle tissues. Brain sections revealed with strong expression in submeningeal round cells (lymphocytes), other leukocytes (neutrophils and microglial cells), and some degenerated glial and neuronal cells. Additionally, the vascular endothelial cells were highly expressed (blue arrows). Muscle sections displayed strong immunoreactivity in degenerated muscle fibers, infiltrating inflammatory cells, and dilated intramuscular capillary endothelium (blue arrows) (Fig. 3C). Similar immunoreactivity was observed in control groups of brain tissue infected with T. gondii GII and GIII (Fig. 3A), whereas GVI showed moderate expression in brain tissue with high expressed vascular endothelial cells (blue arrows) (Fig.3E). In contrast, muscle sections from the control group infected with T. spiralis GIV exhibited low iNOS expression (Fig. 2B).
Fig. 3:
Immunostained photomicrograph of iNOS and Arginase (scale bars 25um, 50 um)
Arginase activity was extremely low in microglial cells and some degenerated neuronal cells, with mild reactivities in some degenerated muscle fibers in the targeted coinfected GV mice (yellow arrows) (Fig.3D). Brain tissue control groups infected with T. gondii GII and GIII exhibited comparable immunoreactivity (Fig.3A). In GVI, low expression was observed in sub-meningeal infiltrated round cells (lymphocytes) and in some degenerated glial and neuronal cells, as well as mild reactivity in some degenerated muscle fibers and mildly dilated intramuscular capillary endothelia (blue arrows) (Fig.3F). In contrast, the strong expression was observed in the degenerated muscle fibers and vascular endothelial cells of GIV (blue arrows) (Fig.3B).
Discussion
The nature of the immune response to infection is influenced by the nature of the infecting organism. In addition to classical macrophage activity, T. gondii induces a Th1-immune response. T. spiralis induces Th2 responses. Given the prevalence of coinfections with these parasites in the field (30), it is crucial to understand how the unique characteristics of each parasite’s immune responses may affect or counter-regulate the immune responses of the other. In this study, T. gondii infection inhibited the local and systemic Th2 responses normally induced by infection with T. spiralis. The T. spiralis larval load was significantly reduced in the coinfected groups with high and low doses of T. gondii compared to the T. spiralis-infected GIV by 75.2% and 68.2%, respectively. The prevalence of T. gondii brain cysts decreased negligibly in both groups.
This study suggests that T. gondii infection can inhibit the host's ability to generate a Th2-polarized immune response to coinfection with T. spiralis. The development of a Th2-polarized immune response to certain helminth infections was inhibited in mice coinfected with malaria (31, 32). Our findings support these findings. These results suggest that a robust Th1-targeted immune response to T. gondii infection may inhibit the development of Th2-polarized immune responses to coinfection with helminths (33). As long as T. spiralis has no effect on the Th1 response of T. gondii; the effect of T. spiralis on the toxoplasmosis parasite burden in coinfected mice was insignificant. The observed decrease in Th2 responses may be attributable to perturbed priming and polarization events at various stages, such as insufficient stimulation of naive CD4+ helper T cells and altered dendritic cell function. Additionally, infection with T. gondii impairs the formation and function of naive T cells (34).
TsSP and ROP18 expression were measured to confirm that a decrease in the parasite load correlates with a decrease in parasite virulence. ROP18 plays a crucial role in determining the virulence of T. gondii infections (35). TsSP expression was significantly reduced in muscle tissue of the targeted coinfected GV (96.2%) and GVI (86.7%) compared to the control GIV. Although there was a slight shift in ROP18 expression in the brain tissue of the targeted GV and GVI by 6% and 10.6%, respectively, there was no significant difference. TsSP plays a role in the invasion of the intestinal epithelial cells of the host by T. spiralis; therefore, a decrease in TsSP expression indicated a decrease in the burden of muscle larvae (25, 36).
We examined isotype-specific antibody reactions against the investigated parasites to establish that the standard Th2 and Th1 responses were initiated in our targeted coinfection scenario, as IgG antibodies are essential for preventing the parasite infection. Compared to GI, the levels of IgG2a antibodies in the targeted coinfected GV and GVI groups increased. These results suggest that T. gondii enhances the humoral response mediated by the major subclass antibody IgG2a. However, throughout the experiment, IgG1 levels were negligible. These findings imply that infection with T. gondii induces an IgG2a (Th1)-dominant antibody response. These results may be attributed toTh1-polarizing cytokines that protect against intracellular pathogens (37) and prevent the transition of T cells into Th2 responses, decreasing Th2-type cytokine secretion (38). Our findings are consistent with those of Bokken et al. (39), who found that coinfection with T. gondii and T. spiralis in pigs may result in the production of specific serum antibody responses.
Coinfection with T. gondii and T. spiralis altered the normal pathological results of T. spiralis, corroborating our findings. Surprisingly, mild T. spiralis infection was observed in the targeted GIV and GV coinfected muscle tissues. Compared to the control GIV, the inflammatory response gradually diminished to the point where the cells resumed their normal architectures (Fig. 1B and C). Consistent with our findings, Xu et al. (40) demonstrated that T. gondii eased the liver fibrosis induced by Schistosoma japonicum. Moreover, Miller et al. (30) established that T. gondii inhibited Fasciola hepatica infection responses.
The activation of macrophages was determined by examining the immunohistochemical staining expression of iNOS and arginase. The muscle sections of the targeted GV demonstrated high iNOS expression and very low arginine-1expression. This can be explained by the transition from a Th2-dominant to a T. gondii Th1-dominant response, as well as the production of macrophage-derived NO from arginine by the iNOS (41). During T. spiralis mono-infection, alternatively activated macrophages produce a substantial amount of arginase-1. Reduced protection against T. gondii in coinfected animals is associated with an increase in M1 cell activation in mice infected with type II Toxoplasma, while classically activated macrophages (CaMs) increase iNOS expression (42). This study demonstrates how macrophage polarization and the relative levels of iNOS and arginase-1 production in response to the parasite infection may influence the host's ability to co-infect with different parasites. Most human toxoplasmosis cases are caused by genotype II, which ME49 corresponds to in the current study. Therefore, we believe that our mouse-model-based findings are useful for understanding the relationship between T. gondii and T. spiralis infections in humans (43).
Conclusion
Infection with T. gondii induces a shift toward a Th1-type immune response while suppressing a helminth-specific Th2 immune response. Our findings suggest that the clear antagonistic activity of T. gondii against T. spiralis is due to cross-immunity. T. gondii induces robust Th1 responses, which are characterized by early, classical macrophage activation and the production of inflammatory mediators, including IFN-c, NO, and IL-12. These reactions are sufficient to prevent alternative macrophage activation and, consequently, the Th2 responses associated with T. spiralis infection. Moreover, these findings may also facilitate the creation of new vaccines.
Footnotes
Conflict of interest
The authors disclose no conflicts of interest.
References
- 1.Labeaud AD, Malhotra I, King MJ, et al. Do antenatal parasite infections devalue childhood vaccination? PLoS Negl Trop Dis. 2009; 3 (5): e442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Thumbi SM, Bronsvoort BMC, Poole EJ, et al. Parasite co-infections and their impact on survival of indigenous cattle. PLoS One. 2014; 9 (2): e76324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Griffiths EC, Pedersen AB, Fenton A, et al. The nature and consequences of coinfection in humans. J Infect. 2011; 63 (3):200–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Cox FE. Concomitant infections, parasites, and immune responses. Parasitology. 2001;122 (S1): S23–S38. [DOI] [PubMed] [Google Scholar]
- 5.Babu S, Nutman TB. Immune responses to helminth infection. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, eds. Clinical Immunology. 5th ed. Elsevier; 2019. p. 437–447. [Google Scholar]
- 6.Ashour DS. Trichinella spiralis immunomodulation: An interactive multifactorial process. Expert Rev Clin Immunol. 2013; 9 (7):669–675. [DOI] [PubMed] [Google Scholar]
- 7.Ortega-Pierres G, Vaquero-Vera A, Fonseca-Linan R, et al. Induction of protection in murine experimental models against Trichinella spiralis: An up-to-date review. J Helminthol. 2015; 89 (5): 526–539. [DOI] [PubMed] [Google Scholar]
- 8.Zhao Z, Sun HQ, Wei SS, et al. Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection. Sci Rep.2015; 5:12371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dubey JP. The history of Toxoplasma gondii–the first 100 years. J Eukaryot Microbiol.2008;55 (6): 467–475. [DOI] [PubMed] [Google Scholar]
- 10.Bahia-Oliveira LM, da Silva JA, Peixoto-Rangel AL, et al. Host immune response to Toxoplasma gondii and Ascaris lumbricoides in an endemic area: Evidence of parasite coimmunomodulation properties influencing the outcome of both infections. Mem Inst Oswaldo Cruz. 2009; 104 (2): 273–280. [DOI] [PubMed] [Google Scholar]
- 11.Owyang AM, Zaph C, Wilson EH, et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med. 2006; 203 (4): 843–849. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mulcahy G, Joyce P, Dalton JP. Immunology of Fasciola hepatica infection. In: Dalton J.P., ed. Fasciolosis;1999. p. 341–375. [Google Scholar]
- 13.Khan A, Taylor S, Ajioka JW, et al. Selection at a single locus leads to widespread expansion of Toxoplasma gondii lineages that are virulent in mice. PLoS Genet.2009; 5 (3): e1000404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sun GG, Song YY, Jiang P, et al. Characterization of a Trichinella spiralis putative serine protease. Study of its potential as sero-diagnostic tool. PLoS Negl Trop Dis. 2018; 12 (5): e0006485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nishi L, Santana PL, Evangelista FF, et al. Rosuvastatin reduced brain parasite burden in a chronic toxoplasmosis in vivo model and influenced the neuropathological pattern of ME-49 strain. Parasitology. 2020;147 (3): 303–309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.AbdelHamed EF, Mostafa NE, Fawzy EM, et al. The delayed death-causing nature of Rosmarinus officinalis leaf extracts and their mixture within experimental chronic toxoplasmosis: Therapeutic and prophylactic implications. Acta Tropica. 2021; 221:105992. [DOI] [PubMed] [Google Scholar]
- 17.AbdelHamed EF, Mostafa NE, Saleh AA, et al. Artesunate loaded nanofiber and its combinations with spiramycin for treatment of murine toxoplasmosis. J Egypt Soc Parasitol. 2019; 49 (1): 135–144. [Google Scholar]
- 18.Li F, Wang ZQ, Cui J. Early detection by polymerase chain reaction of migratory Trichinella spiralis larvae in blood of experimentally infected mice. Foodborne Pathog Dis.2010; 7 (8):887–892. [DOI] [PubMed] [Google Scholar]
- 19.Angkasekwinai P, Sodthawon W, Jeerawattanawart S, et al. ILC2s activated by IL-25 promote antigen-specific Th2 and Th9 functions that contribute to the control of Trichinella spiralis infection. PLoS One. 2017; 12 (9): e0184684. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Bruschi F, Bianchi C, Fornaro M, et al. Pinto B Matrix metalloproteinase (MMP)-2 and MMP-9 as inflammation markers of Trichinella spiralis and Trichinella pseudospiralis infections in mice. Parasite Immunol. 2014; 36 (10): 540–549. [DOI] [PubMed] [Google Scholar]
- 21.Kapel CMO, Gamble HR. Infectivity, persistence, and antibody response to domestic and sylvatic Trichinella spp. In experimentally infected pigs. Int J Parasitol.2000; 30 (2):215–221. [DOI] [PubMed] [Google Scholar]
- 22.Barakat AMA. Some diagnostic studies on male New Zealand rabbit experimentally infected with Toxoplasma gondii strain. Glob Vet. 2007; 1 (1):17–23. [Google Scholar]
- 23.Fux B, Nawas J, Khan A, et al. Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation. Infect Immun.2007; 75 (5):2580–2590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Sánchez V, de-la-Torre A, Gómez-Marín JE. Characterization of ROP18 alleles in human toxoplasmosis. Parasitol Int. 2014; 63 (2): 463–469. [DOI] [PubMed] [Google Scholar]
- 25.Song YY, Zhang Y, Ren HN, et al. Characterization of a serine protease inhibitor from Trichinella spiralis and its participation in larval invasion of host’s intestinal epithelial cells. Parasites Vectors. 2018; 11: 499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Yuan JS, Reed A, Chen F, Stewart CN. Statistical analysis of real-time PCR data. BMC Bioinformatics. 2006; 7:85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Suvarna SK, Layton C, Bancroft JD. Bancroft’s theory and practice of histological techniques. 7thed. 2013.
- 28.Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168 (4): 357–363. doi: 10.1002/path.1711680404 [DOI] [PubMed] [Google Scholar]
- 29.Hsu SM, Raine L, Fanger H. Use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. I981; 29 (4):577–580. [DOI] [PubMed] [Google Scholar]
- 30.Miller CMD, Smith NC, Ikin RJ, et al. Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing Helminth Fasciola hepatica. PLoS One.2009; 4 (5): e5692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hoeve MA, Mylonas KJ, Fairlie-Clarke KJ, et al. Plasmodium chabaudi limits early Nippostrongylus brasiliensis-induced pulmonary immune activation and Th2 polarization in co-infected mice. BMC Immunol. 2009; 10:60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Karadjian G, Berrebi D, Dogna N, et al. Co-infection restrains Litomosoides sigmodont is filarial load and plasmodial P. yoelii but not P. chabaudi parasitaemia in mice. Parasite. 2014; 21:16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ahmed N, French T, Rausch S, et al. Hartmann S . Toxoplasma co-infection prevents Th2 differentiation and leads to a helminth-specific Th1 response. Front Cell Infect Microbiol. 2017; 7:341. doi: 10.3389/fcimb.2017.00341 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kugler DG, Flomerfelt FA, Costa DL, et al. Systemic Toxoplasma infection triggers a long-term defect in the generation and function of naive T lymphocytes. J Exp Med. 2016; 213 (13): 3041–3056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lei T, Wang H, Liu J, et al. ROP18 is a key factor responsible for virulence difference between Toxoplasma gondii and Neospora caninum. PLoS One. 2014; 9 (6): e99744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yi N, Yu P, Wu L, et al. RNAi-mediated silencing of Trichinella spiralis serpin-type serine protease inhibitors results in a reduction in larval infectivity. Vet Res.2020; 51: 139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Meira CS, Pereira-Chioccola VL, Vidal JE, et al. Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels. Front Microbiol. 2014; 5: 492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Munoz M, Liesenfeld O, Heimesaat MM. Immunology of Toxoplasma gondii. Immunol. Rev.2011; 240 (1): 269–285. [DOI] [PubMed] [Google Scholar]
- 39.Bokken GC, van Eerden E, Opsteegh M, et al. Specific serum antibody responses following a Toxoplasma gondii and Trichinella spiralis co-infection in swine. Vet Parasitol. 2012; 184 (2–4):126–132. [DOI] [PubMed] [Google Scholar]
- 40.Xu F, Cheng R, Miao S, et al. Prior Toxoplasma gondii infection ameliorates liver fibrosis induced by Schistosoma japonicum through inhibiting Th2 response and improving balance of intestinal flora in mice. Int J Mol Sci.2020; 21 (8): 2711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Aliberti J. Host persistence: Exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat Rev Immunol. 2005; 5 (2): 162–170. [DOI] [PubMed] [Google Scholar]
- 42.Butcher BA, Fox BA, Rommereim LM, et al. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. PLoS Pathog.2011; 7 (9): e1002236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Howe DK, Honoré S, Derouin F, et al. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol.1997; 35 (6): 1411–1414. [DOI] [PMC free article] [PubMed] [Google Scholar]



